|Articles|July 10, 2023
DIA 2023: Where Does Industry Currently Stand with eConsent?
Hilde Vanaken, PhD, head, European Forum GCP (EFGCP) eConsent Initiative, and head, TCS Industry Leaders discusses takeaways from a 2023 DIA session she spoke at on eConsent.
Advertisement
In an interview at the 2023 DIA annual meeting with ACT editor, Andy Studna, Hilde Vanaken, PhD, head, European Forum GCP (EFGCP) eConsent Initiative, and head, TCS Industry Leaders discusses where industry is currently at with increasing adoption of eConsent as well as takeaways from a session she spoke at with FDA and MHRA.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Verana Health Merges With COTA to Expand Real-World Data Capabilities Across Oncology and Specialty Care
2
Why Trial Competition Is Undermining AI-Driven Gains
3
ACT Brief: Recalibrating Trial Efficiency and Access, Verana-COTA Merge to Expand RWE Scale, and FDA Rejects Hetlioz Jet Lag Indication
4
Reasoning About Individual Drug Causality in a Multifactorial World
5